Becton, Dickinson and Company
Clinical trials sponsored by Becton, Dickinson and Company, explained in plain language.
Becton, Dickinson and Company
BDX
NYSE
Medical technology company producing devices, instruments, and reagents.
Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
Advertising disclosure. Links marked "(ad)" go to partners we have a commercial relationship with, either a broker where you can trade or a stock-research service, and we may earn a commission if you open an account or subscribe. This never affects what is shown here.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New external catheter could replace painful internal tubes for women Results expected Nov 2026 (estimated)
- New monitor tested in transplant patients to improve care Results expected Nov 2026 (estimated)
- Brain-Safe bypass: smart monitor aims to personalize blood pressure during heart surgery Results expected Jan 2027 (estimated)
- Finger cuff could spot dangerous drops in blood pressure during surgery Results expected Jan 2027 (estimated)
- A gentler catheter may cut infection risk for women in hospitals Results expected Jun 2027 (estimated)